commonli
use
highli
versatil
techniqu
separ
protein
accord
size
charg
protein
bodi
fluid
tissu
cell
first
separ
thin
gel
layer
accord
isoelectr
charg
first
dimens
gel
place
across
larger
gel
protein
separ
second
dimens
right
angl
first
accord
size
techniqu
separ
resolv
protein
per
gel
individu
protein
excis
purifi
identif
usual
mass
spectrometri
see
box
mass
spectrometri
revolutionis
proteom
allow
thousand
protein
analys
rapidli
first
develop
earli
centuri
techniqu
identifi
substanc
sort
accord
mass
stream
electrifi
particl
ion
deriv
substanc
applic
mass
spectrometri
protein
made
possibl
develop
method
ionis
larg
biomolecul
without
destroy
includ
electrospray
ionis
laser
desorpt
ionis
maldi
mass
spectrometri
protein
digest
enzym
usual
trypsin
cleav
specif
amino
acid
sequenc
result
peptid
fragment
energis
often
laser
eg
use
maldi
sometim
electrospray
ionis
charg
peptid
fragment
separ
spectromet
accord
ratio
method
vari
differ
type
spectromet
eg
time
flight
tof
flight
tube
separ
fragment
imping
detector
measur
signal
intens
fragment
graph
signal
intens
ratio
mass
spectrum
box
contain
seri
peak
correspond
particular
peptid
fragment
specif
amino
acid
sequenc
indic
mass
height
repres
rel
abund
fragment
peptid
peak
fragment
give
second
tandem
mass
spectrum
peptid
fragment
differ
neighbour
one
amino
acid
peptid
sequenc
determin
process
term
peptid
mass
fingerprint
peptid
sequenc
interrog
protein
databas
identifi
origin
protein
identif
protein
peptid
sequenc
deriv
mass
spectrum
facilit
develop
proteom
databas
first
major
protein
databas
establish
maintain
collabor
european
institut
other
develop
differ
countri
differ
focus
eg
cell
line
plant
protein
major
databas
includ
protein
inform
resourc
pir
protein
research
foundat
prf
protein
data
bank
pdb
protein
databas
entrez
search
retriev
system
tool
access
search
larg
rang
databas
includ
protein
databas
literatur
databas
pubm
made
avail
us
nation
center
biotechnolog
inform
ncbi
nation
librari
medicin
protein
entri
system
contain
amino
acid
sequenc
protein
databas
pir
prf
pdb
well
amino
acid
sequenc
translat
dna
sequenc
genet
databas
genbank
continu
develop
improv
proteom
technolog
dige
box
liquid
chromatographi
link
mass
spectrometri
allow
protein
detect
high
sensit
specif
small
volum
biolog
sampl
blood
urin
plasma
protein
current
detect
concentr
rang
develop
mass
spectromet
combin
techniqu
remov
interf
protein
immunodeplet
enabl
even
lower
concentr
detect
addit
protein
microarray
system
chip
develop
surfac
bind
select
protein
prepar
mass
spectrometri
analog
dna
chip
protein
chip
aim
bind
individu
protein
biolog
sampl
serum
urin
allow
screen
protein
proteom
diseas
studi
focus
cancer
proteom
potenti
allow
earlier
diagnosi
particularli
import
ovarian
cancer
women
cancer
advanc
diseas
diagnosi
surviv
rate
howev
stage
ovarian
cancer
surviv
rate
earli
diagnosi
like
directli
affect
mortal
proteom
studi
identifi
serum
protein
pattern
distinguish
patient
ovarian
cancer
unaffect
women
posit
predict
valu
howev
number
assess
small
result
proven
difficult
reproduc
highlight
need
identifi
protein
interest
determin
biolog
plausibl
test
also
undertak
prospect
assess
determin
valu
proteom
pattern
screen
tool
ovarian
cancer
identifi
protein
involv
also
import
potenti
therapeut
target
case
cancer
abdomen
occasion
difficult
determin
tissu
origin
consequ
optim
therapi
exampl
ovarian
colon
cancer
difficult
distinguish
correct
diagnosi
essenti
treatment
vari
markedli
use
combin
genom
proteom
tool
investig
abl
identifi
differenti
marker
two
cancer
protein
villin
colon
cancer
cell
moesin
ovarian
cancer
cell
tuberculosi
affect
million
peopl
worldwid
mycobacterium
tuberculosi
strain
increas
problem
serum
screen
test
could
detect
infect
would
allow
earli
treatment
potenti
reduc
transmiss
widespread
applic
proteom
techniqu
identifi
protein
secret
vitro
common
clinic
isol
two
shown
potenti
serodiagnost
antigen
sensit
specif
clinic
studi
protein
potenti
candid
serum
screen
test
pathogenesi
sever
acut
respiratori
syndrom
sar
well
understood
specif
diagnost
method
critic
manag
control
diseas
proteom
analysi
sera
patient
sar
identifi
potenti
protein
marker
truncat
form
consist
found
higher
concentr
sera
sar
patient
compar
healthi
control
marker
may
prove
use
diagnost
tool
therapeut
target
moreov
studi
protein
structur
sar
viru
may
reveal
potenti
vaccin
target
immun
reject
major
problem
cardiac
transplant
accur
diagnosi
reli
invas
endomyocardi
biopsi
recent
studi
cardiac
biopsi
specimen
identifi
protein
upregul
reject
includ
cardiac
heat
shock
protein
latter
upregul
stress
respons
two
heat
shock
protein
tropomyosin
cardiac
muscl
protein
express
significantli
higher
level
sera
patient
undergo
reject
proteom
analysi
serum
may
therefor
power
less
invas
method
identifi
cardiac
reject
although
still
infanc
proteom
strategi
also
use
investig
differenti
protein
express
cancer
cell
may
reflect
differ
invas
predisposit
develop
resist
treatment
exampl
proteom
identifi
protein
involv
multidrug
resist
major
vault
protein
metastasi
cystatin
b
highli
express
glioblastoma
multiform
compar
normal
brain
tissu
protein
potenti
diagnost
drug
resist
invas
marker
glioblastoma
tumor
identifi
proteom
profil
associ
intrins
acquir
drug
resist
might
allow
treatment
vari
avoid
resist
hypothet
might
also
possibl
identifi
tumour
highli
allow
lower
drug
dose
use
potenti
reduc
drug
toxic
resist
cancer
cell
chemotherapi
multifacet
understand
caus
could
improv
use
exist
therapi
potenti
reveal
new
treatment
strategi
recent
proteom
studi
childhood
acut
lymphoblast
leukaemia
cell
identifi
specif
protein
chang
compar
cell
identifi
protein
differ
structur
quantiti
cell
resist
vinca
alkaloid
sensit
cytoskelet
protein
eg
actin
protein
regul
bind
cytoskelet
protein
eg
heat
shock
protein
protein
involv
rna
process
eg
heterogen
nuclear
ribonuclear
protein
previous
associ
drug
resist
studi
way
determin
potenti
novel
drug
target
treat
resist
diseas
addit
novel
antimitot
agent
epothilon
current
undergo
clinic
trial
cancer
treatment
studi
combin
biochem
proteom
approach
identifi
uniqu
chang
mutat
affect
tubulin
cellular
target
epothilon
leukaemia
cell
found
leukaemia
cell
paclitaxel
hypersensit
vinca
alkaloid
studi
demonstr
laboratori
studi
target
specif
protein
alter
reveal
altern
treatment
approach
drug
resist
also
major
clinic
problem
treatment
mani
infecti
diseas
mani
case
mechan
unknown
genet
data
avail
mani
microorgan
provid
tool
understand
resist
drug
identifi
novel
agent
treat
diseas
exampl
azol
resist
candida
albican
link
differenti
express
protein
protein
involv
ergosterol
biosynthesi
pathway
potenti
drug
target
treatment
resist
diseas
chloroquin
one
success
drug
treat
malaria
render
virtual
ineffect
mani
part
world
widespread
emerg
chloroquin
resist
proteom
technolog
play
major
role
identifi
potenti
therapeut
target
plasmodium
speci
well
interact
interact
advanc
date
includ
identif
differ
plasmodium
speci
identif
immun
target
vaccin
immun
protect
better
understand
cellular
target
chloroquin
mechan
chloroquin
resist
proteom
expect
major
impact
drug
develop
near
futur
protein
differenti
express
health
diseas
potenti
drug
target
test
commerci
avail
librari
chemic
compound
identifi
lead
compound
compound
vitro
activ
target
potenti
new
therapi
exploit
new
knowledg
develop
better
treatment
next
challeng
still
technic
challeng
overcom
proteom
must
deal
complex
mixtur
tissu
sampl
bodi
fluid
divers
sampl
complic
fact
protein
variou
isoform
variant
averag
singl
gene
produc
three
protein
protein
undergo
modif
phosphoryl
glycosyl
increas
function
divers
furthermor
variou
gene
product
modif
differenti
tissu
express
function
protein
express
low
level
organ
cell
protein
transcript
factor
protein
often
swamp
analysi
protein
eg
cytoskelet
protein
albumin
immunoglobulin
protein
fraction
enrich
techniqu
immunodeplet
may
concentr
protein
analysi
combin
increas
sensit
instrument
start
overcom
problem
proteom
pattern
profil
offer
enorm
hope
earli
detect
diseas
obstacl
remain
becom
commonplac
clinic
practic
mass
spectrometri
identifi
thousand
protein
complex
algorithm
still
need
develop
valid
order
identifi
specif
versu
chang
effect
sampl
type
qualiti
proteom
pattern
normal
variat
need
investig
issu
cost
data
manag
need
resolv
differ
sampl
may
specif
storag
requir
preserv
protein
integr
consider
includ
effect
treatment
proteom
profil
major
challeng
integr
biochem
genet
proteom
data
better
understand
organ
diseas
state
system
biolog
emerg
scienc
aim
integr
studi
organ
term
fundament
structur
rather
individu
cellular
molecular
system
anyth
gene
regul
cell
tissu
organ
organ
biochem
interact
given
time
place
cell
system
biolog
requir
simultan
investig
interact
compon
proteom
contribut
multidisciplinari
approach
studi
diseas
bioinformat
comput
skill
requir
deal
interpret
complex
biolog
system
proteom
analysi
human
diseas
move
ahead
rapidli
appli
find
improv
understand
role
individu
protein
entir
cellular
pathway
initi
develop
diseas
intern
human
proteom
organis
hupo
form
vision
consolid
nation
region
proteom
organis
worldwid
network
encourag
spread
proteom
technolog
dissemin
knowledg
human
proteom
proteom
model
organ
effort
hupo
organis
databas
develop
proteom
normal
diseas
tissu
initi
help
acceler
investig
diseas
excit
challeng
integr
data
genom
analysi
differenti
function
structur
studi
protein
cross
refer
biolog
process
occur
diseas
develop
databas
expedit
analysi
clinic
sampl
earli
detect
prognost
diagnost
therapeut
test
strategi
avail
doctor
ultim
patient
grate
acknowledg
support
children
cancer
institut
australia
medic
research
affili
univers
new
south
wale
sydney
children
hospit
sydney
nsw
kavallari
support
nation
health
medic
research
council
rd
wright
career
develop
award
none
identifi
